Test of Aquatic Mobility of SMA Infants

Recruiting N/A Interventional Study
Infantile Spinal Muscular Atrophy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 12 Months
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
15 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Spinal muscular atrophy (SMA) is a genetic neurodegenerative disease impacting spinal cord motor neurons, leading to motor and respiratory issues and, ultimately, death. With emerging therapies, a need arises to enhance motor function assessment in severely hypotonic infants (SMA type 1) as traditional scales on examination tables lack completeness due to gravity's influence. The study team has d…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Infants with muscle weakness (commonly referred to as floppy babies): * Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene). * Receiving standard care. * Age less than 12 years and a height of less than 90 cm at the time of inclusion. * Patients enr…
Contacts

Susana Quijano-Roy, MD, PhD

+ 33 1 47 10 78 90

susana.quijano-roy@aphp.fr

CONTACT

Nour Maalouf, Psychomotor Therapist DE

nour.maalouf@outlook.com

CONTACT